Dalbeth N - Search Results

1

Stamp LK, Dalbeth N. Stamp LK, et al. Among authors: dalbeth n. Nat Rev Rheumatol. 2019 Feb;15(2):68-70. doi: 10.1038/s41584-018-0149-7. Nat Rev Rheumatol. 2019. PMID: 30546062 Review. No abstract available.

2

Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.

Dalbeth N, Kumar S, Stamp L, Gow P. Dalbeth N, et al. J Rheumatol. 2006 Aug;33(8):1646-50. J Rheumatol. 2006. PMID: 16783857

3

Clinical images: three-dimensional computed tomography imaging of tophaceous gout.

Dalbeth N, Clark B, Gregory K, Sheehan T, McQueen F. Dalbeth N, et al. Arthritis Rheum. 2007 Jan;56(1):29. doi: 10.1002/art.22297. Arthritis Rheum. 2007. PMID: 17195196 Free article. No abstract available.

4

Assessment of outcome in clinical trials of gout--a review of current measures.

Taylor WJ, Schumacher HR Jr, Singh JA, Grainger R, Dalbeth N. Taylor WJ, et al. Among authors: dalbeth n. Rheumatology (Oxford). 2007 Dec;46(12):1751-6. doi: 10.1093/rheumatology/kem178. Epub 2007 Jul 24. Rheumatology (Oxford). 2007. PMID: 17650521 Review.

5

Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.

Dalbeth N, Stamp L. Dalbeth N, et al. Semin Dial. 2007 Sep-Oct;20(5):391-5. doi: 10.1111/j.1525-139X.2007.00270.x. Semin Dial. 2007. PMID: 17897242

6

A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout.

Taylor WJ, Schumacher HR Jr, Baraf HS, Chapman P, Stamp L, Doherty M, McQueen F, Dalbeth N, Schlesinger N, Furst DE, Vazquez-Mellado J, Becker MA, Kavanaugh A, Louthrenoo W, Bardin T, Khanna D, Simon LS, Yamanaka H, Choi HK, Zeng X, Strand V, Grainger R, Clegg D, Singh JA, Diaz-Torne C, Boers M, Gow P, Barskova VG. Taylor WJ, et al. Among authors: dalbeth n. Ann Rheum Dis. 2008 Jun;67(6):888-91. doi: 10.1136/ard.2007.079970. Epub 2007 Nov 29. Ann Rheum Dis. 2008. PMID: 18055475

7

Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis.

Hollis-Moffatt JE, Merriman ME, Rodger RA, Rowley KA, Chapman PT, Dalbeth N, Gow PJ, Harrison AA, Highton J, Jones PB, O'Donnell JL, Stamp LK, Merriman TR. Hollis-Moffatt JE, et al. Among authors: dalbeth n. Ann Rheum Dis. 2009 Aug;68(8):1340-4. doi: 10.1136/ard.2008.090142. Epub 2008 Jul 22. Ann Rheum Dis. 2009. PMID: 18647855

8

The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout.

Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N. Taylor WJ, et al. Among authors: dalbeth n. Clin Exp Rheumatol. 2008 Jul-Aug;26(4):620-6. Clin Exp Rheumatol. 2008. PMID: 18799093

9

Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout.

Dalbeth N, Merriman T. Dalbeth N, et al. Rheumatology (Oxford). 2009 Mar;48(3):222-6. doi: 10.1093/rheumatology/ken460. Epub 2008 Dec 24. Rheumatology (Oxford). 2009. PMID: 19109320 Review.

10

Use of imaging to evaluate gout and other crystal deposition disorders.

Dalbeth N, McQueen FM. Dalbeth N, et al. Curr Opin Rheumatol. 2009 Mar;21(2):124-31. doi: 10.1097/BOR.0b013e3283257b6c. Curr Opin Rheumatol. 2009. PMID: 19339922 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

631 results

Search Page

Filters